Literature DB >> 2335327

Further evaluation of immunocytochemical staining in the diagnosis of early myocardial ischaemic/hypoxic damage.

S Leadbeatter1, H M Wawman, B Jasani.   

Abstract

The pattern of immunocytochemical staining with antibodies to caeruloplasmin, myosin, myoglobin and C-reactive protein seen in myocardium taken from deaths with macroscopic evidence of myocardial infarction and/or significant coronary artery atherosclerosis and from deaths with neither of these lesions has been correlated with H&E, PTAH and HBFP staining of myocardium and circumstances of each death indicative of antemortem hypoxia and/or ischaemia. Loss of staining with these antibodies correlated well with fuchsinorrhagia and both techniques are more sensitive than H&E and PTAH staining in the detection of early ischaemic/hypoxic damage to myocardium. However, their sensitivity is such that they appear to detect agonal changes and, therefore, cannot be used for specific diagnosis of early myocardial infarction.

Entities:  

Mesh:

Year:  1990        PMID: 2335327     DOI: 10.1016/0379-0738(90)90230-v

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  3 in total

Review 1.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

2.  The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage.

Authors:  B Brinkmann; M A Sepulchre; G Fechner
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

3.  Immunohistochemical detection of early myocardial infarction. An evaluation of antibodies against the terminal complement complex (C5b-9).

Authors:  E Edston; K Kawa
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.